Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Erratum: Field Cancerization in Sporadic Colon Cancer

Park SK, Song CS, Yang HJ, Jung YS, Choi KY, Koo DH, Kim KE, Jeong KU, Kim HO, Kim H, Chun HK, Park DI

  • Gut Liver.
  • 2016 Nov;10(6):981-981.
  • doi: 10.5009/gnl10061
In the version of this article initially published, the first affiliation (affiliation number 1) was incorrectly stated as "Division of Gastroentorology, Department of Internal Medicine." The correct affiliation is "Department...
Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis

Ni X, Fan S, Zhang Y, Wang Z, Ding L, Li Y, Li J

  • Gut Liver.
  • 2016 Nov;10(6):975-980.
  • doi: 10.5009/gnl15456
Since its introduction as an alternative intestinal microbiota alteration approach, fecal microbiota transplantation (FMT) has been increasingly used as a treatment of choice for patients with ulcerative colitis (UC), but...
A Double-Layered Covered Biliary Metal Stent for the Management of Unresectable Malignant Biliary Obstruction: A Multicenter Feasibility Study

Park JS, Jeong S, Lee DH, Moon JH, Lee KT, Dong SH

  • Gut Liver.
  • 2016 Nov;10(6):969-974.
  • doi: 10.5009/gnl15112
BACKGROUND/AIMS: The covered self-expandable metal stent (CMS) was developed to prevent tumor ingrowth-induced stent occlusion during the treatment of malignant biliary obstruction. However, complications such as cholecystitis, pancreatitis, and stent...
Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B

Shim JJ, Oh IH, Kim SB, Kim JW, Lee CK, Jang JY, Lee JS, Kim BH

  • Gut Liver.
  • 2016 Nov;10(6):962-968.
  • doi: 10.5009/gnl15426
BACKGROUND/AIMS: The benefit of oral antiviral therapy in preventing hepatocellular carcinoma (HCC) in the general population is not well understood. We used a novel prediction method to estimate the risk...
Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study

Zeng QL, Li B, Zhang XX, Chen Y, Fu YL, Lv J, Liu YM, Yu ZJ

  • Gut Liver.
  • 2016 Nov;10(6):955-961.
  • doi: 10.5009/gnl15321
BACKGROUND/AIMS: No clinical model exists to predict the occurrence of hepatocellular carcinoma in sustained virologic response-achieving (HCC after SVR) patients with chronic hepatitis C (CHC). METHODS: We performed a case-control study...
The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma

Jang SY, Park SY, Lee HW, Choi YK, Park KG, Yoon GS, Tak WY, Kweon YO, Hur K, Lee WK

  • Gut Liver.
  • 2016 Nov;10(6):948-954.
  • doi: 10.5009/gnl15481
BACKGROUND/AIMS: Periostin is an extracellular matrix protein and is known to be related to the metastatic potential and prognosis of cancer. However, few studies have investigated the expression level of...
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma

Kim JH, Sinn DH, Kim K, Kim H, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW

  • Gut Liver.
  • 2016 Nov;10(6):939-947.
  • doi: 10.5009/gnl15527
BACKGROUND/AIMS: Antiviral therapy is a key component in the management of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients. However, whether the potent drug entecavir is more effective than a...
Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production

Ghoshal U, Shukla R, Srivastava D, Ghoshal UC

  • Gut Liver.
  • 2016 Nov;10(6):932-938.
  • doi: 10.5009/gnl15588
BACKGROUND/AIMS: Because Methanobrevibacter smithii produces methane, delaying gut transit, we evaluated M. smithii loads in irritable bowel syndrome (IBS) patients and healthy controls (HC). METHODS: Quantitative real-time polymerase chain reaction for...
Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial

Shin HY, Suh M, Baik HW, Choi KS, Park B, Jun JK, Hwang SH, Kim BC, Lee CW, Oh JH, Lee YK, Han DS, Lee DH

  • Gut Liver.
  • 2016 Nov;10(6):925-931.
  • doi: 10.5009/gnl15479
BACKGROUND/AIMS: We are in the process of conducting a randomized trial to determine whether compliance with the fecal immunochemical test (FIT) for colorectal cancer screening differs according to the stool-collection...
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy

Nakamura K, Ihara E, Akiho H, Akahoshi K, Harada N, Ochiai T, Nakamura N, Ogino H, Iwasa T, Aso A, Iboshi Y, Takayanagi R

  • Gut Liver.
  • 2016 Nov;10(6):917-924.
  • doi: 10.5009/gnl15486
BACKGROUND/AIMS: The ability of endoscopic submucosal dissection (ESD) to resect large early gastric cancers (EGCs) results in the need to treat large artificial gastric ulcers. This study assessed whether the...
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study

Hong SJ, Park SH, Moon JS, Shin WG, Kim JG, Lee YC, Lee DH, Jang JY, Kim JJ, Lee HL, Lee SW, Hwangbo Y, Xu J, Wang B, Xue Z, Liu F, Yuan Y, Leelakusolvong S, Dy F

  • Gut Liver.
  • 2016 Nov;10(6):910-916.
  • doi: 10.5009/gnl15537
BACKGROUND/AIMS: To investigate the effects of esomeprazole and rebamipide combination therapy on symptomatic improvement in patients with reflux esophagitis. METHODS: A total of 501 patients with reflux esophagitis were randomized into...
Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm

Lee JY, Park HW, Choi JY, Lee JS, Koo JE, Chung EJ, Chang HS, Choe J, Yang DH, Myung SJ, Jung HY, Yang SK, Byeon JS

  • Gut Liver.
  • 2016 Nov;10(6):902-909.
  • doi: 10.5009/gnl15340
BACKGROUND/AIMS: Helicobacter pylori is a major risk factor for atrophic gastritis (AG) and gastric cancer. The correlation between H. pylori, AG and colorectal neoplasm (CRN) has only been examined in...
Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study

Shin CM, Kim N, Kim YS, Nam RH, Park JH, Lee DH, Seok YJ, Kim YR, Kim JH, Kim JM, Kim JS, Jung HC

  • Gut Liver.
  • 2016 Nov;10(6):896-901.
  • doi: 10.5009/gnl15529
BACKGROUND/AIMS: To evaluate changes in gut microbiota composition following long-term proton pump inhibitor (PPI) treatment. METHODS: Twenty-four-week-old F344 rats were fed diets with (n=6) or without (n=5) lansoprazole for 50 weeks....
Hepatitis C Virus and Antiviral Drug Resistance

Kim S, Han KH, Ahn SH

  • Gut Liver.
  • 2016 Nov;10(6):890-895.
  • doi: 10.5009/gnl15573
Since its discovery in 1989, hepatitis C virus (HCV) has been intensively investigated to understand its biology and develop effective antiviral therapies. The efforts of the previous 25 years have...
Potassium Channelopathies and Gastrointestinal Ulceration

Han J, Lee SH, Giebisch G, Wang T

  • Gut Liver.
  • 2016 Nov;10(6):881-889.
  • doi: 10.5009/gnl15414
Potassium channels and transporters maintain potassium homeostasis and play significant roles in several different biological actions via potassium ion regulation. In previous decades, the key revelations that potassium channels and...
Management of Pancreatic Calculi: An Update

Tandan M, Talukdar R, Reddy DN

  • Gut Liver.
  • 2016 Nov;10(6):873-880.
  • doi: 10.5009/gnl15555
Pancreatolithiasis, or pancreatic calculi (PC), is a sequel of chronic pancreatitis (CP) and may occur in the main ducts, side branches or parenchyma. Calculi are the end result, irrespective of...
Role of Periostin in Hepatocellular Carcinoma: The Importance of Tumor Microenvironment

Lee JI

  • Gut Liver.
  • 2016 Nov;10(6):871-872.
  • doi: 10.5009/gnl16429
No abstract available.
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!

Kim HY

  • Gut Liver.
  • 2016 Nov;10(6):869-870.
  • doi: 10.5009/gnl16476
No abstract available.
Is It Rationale to Apply Strict Colonoscopic Surveillance in Patients with Helicobacter pylori Associated Chronic Atrophic Gastritis?

Kim JH

  • Gut Liver.
  • 2016 Nov;10(6):867-868.
  • doi: 10.5009/gnl16445
No abstract available.
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?

Lee C, Hong SN

  • Gut Liver.
  • 2016 Nov;10(6):865-866.
  • doi: 10.5009/gnl16438
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr